Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis

Annals of Pharmacotherapy

Volumn 39, Issue 12, 2005, Pages 1984-1989

  Berger, William E ^a,d   Nayak, Anjuli S ^b   Staudinger, Heribert W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Allergy & Asthma Associates of Northern California   (United States)

Author keywords

Allergic rhinitis; Congestion; Corticosteroid; Mometasone furoate

Indexed keywords

CORTICOSTEROID; MOMETASONE FUROATE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAY FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASAL BURNING; NASAL DISCHARGE; NASAL PRURITUS; NOSE CONGESTION; NOSE DISEASE; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SNEEZING; SYMPTOM;

EID: 28644435560     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G202     Document Type: Article

References (23)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(1 suppl):S2-8.
2. van Drunen C, Meltzer EO, Bachert C, Bousquet J, Fokkens WJ. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate. Allergy 2005;60(suppl 80):5-19.
3. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J 2000;79:690-3,696,698.
4. Rappai M, Collop JL, Kemp S, deShazo R. The nose and sleep-disordered breathing: what we know and what we do not know. Chest 2003;124:2309-23.
5. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997;111:170-3.
6. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997;99:S757-62.
7. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 1997;99:S750-6.
8. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997;20:608-13.
9. Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol 2000;105(6pt2):S605-9.
10. The allergy report. American Academy of Allergy, Asthma & Immunology, Milwaukee, WI, 2000. www.theallergyreport.org/reportindex.html (accessed 2005 Oct 14).
11. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004;130:617-29.
12. Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003;91:131-40.
13. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol 2003;90:182-91.
14. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids [German], Arzneimittelforschung 1998;48:956-60.
15. Transgrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002;22:1458-67.
16. Hebert JR, Nolop K, Lutsky BN. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study. Allergy 1996;51:569-76.
17. Graft D, Aaronson D, Chervinsky P, Kaiser H, Melamed J, Pedinoff A, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996;98:724-31.
18. Bronsky EA, Aaronson DW, Berkowitz RB, Chervinsky P, Graft D, Kaiser HB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:51-6.
19. Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol 2003;90:416-21.
20. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997;79:370-8.
21. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;105(6 pt 2):S599-604.
22. Greisner WA 3rd, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19:185-8.
23. Linneberg A, Henrik Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T; Copenhagen Allergy Study. The link between allergic rhinitis and allergic asthma: a prospective population-based study. Allergy 2002;57:1048-52.